As the Director of the Office of Generic Drug Policy (OGDP) for the FDA (which includes the Division of Policy Development and the Division of Legal and Regulatory Support) Maryll W. Toufanian has her fingers on the pulse of pharmaceuticals and their development in the United States. We had the honor of sitting down with Maryll to discuss the state of the world and her experience at the FDA.
Read More